NCT02512757View on ClinicalTrials.gov

A Case-Control Study to Verify Diagnostic Performance of AminoIndex™ Technology

CompletedOBSERVATIONAL
Enrollment

150

Participants

Timeline

Start Date

August 13, 2015

Primary Completion Date

July 17, 2017

Study Completion Date

July 17, 2017

Conditions
Lung Cancer
Trial Locations (3)

21237

Pulmonary and Critical Care Associates of Baltimore, Baltimore

34747

Florida Lung Asthma and Sleep Specialists P.A., Celebration

37232

Vanderbilt-Ingram Cancer Center (VICC), Nashville

All Listed Sponsors
collaborator

Ajinomoto Co., Inc.

INDUSTRY

lead

Innovis LLC

INDUSTRY

NCT02512757 - A Case-Control Study to Verify Diagnostic Performance of AminoIndex™ Technology | Biotech Hunter | Biotech Hunter